Red-Hot Drug Stock Could Be a Buy

This SAGE options signal has had bullish implications in the past

Jan 24, 2018 at 11:14 AM
facebook twitter linkedin


Shares of SAGE Therapeutics Inc (NASDAQ:SAGE) gapped 70% higher on Dec. 7, after the biotech reported well-received data for one of its depression drugs. The shares have yet to slow down, topping out at a record high of $183.05 earlier. Though SAGE stock was trading down 0.4% at $179.85 at last check, if history is any guide, the drug name could still be headed deeper into uncharted territory.

Specifically, SAGE's Schaeffer's Volatility Index (SVI) of 53% ranks in the 4th percentile of its annual range, indicating short-term options are attractively priced at current levels. Since 2008, there have been two other times the stock has been trading near 52-week highs while also sporting a low-ranked SVI, according to data from Schaeffer's Senior Quantitative Analyst Rocky White.

In the wake of those signals, the shares went on to average a one-month gain of 7.1%, and were positive both times. Another move of this magnitude would put the equity north of $194, based on the stock's current price, a new record high.

sage stock daily chart jan 24

And while most analyst are already bullish on SAGE Therapeutics stock -- all 12 maintain a "buy" or better rating, and the average 12-month price target is docked above $200 -- the equity could certainly stand to benefit from a continued round of short covering. Although short interest fell 22.31% in the most recent reporting period, 3.12 million SAGE shares are still sold short. This accounts for 9.23% of the security's available float, or 5.4 times the average daily pace of trading.

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners